ArticleMolecules (Basel, Switzerland)2026
Robust Polyurethane with Ordered Hard Segments and Pendant Fluorinated Chains for Improved Hemocompatibility.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Despite the widespread use of polyurethane (PU) in biomedical devices, its long-term application has been hindered by insufficient hemocompatibility caused by protein adsorption and subsequent thrombosis. In this study, a fluorinated PU (F-PCU) was designed to improve surface hemocompatibility while maintaining mechanical performance and good cytocompatibility. F-PCU was synthesized via a prepolymer method using a fluorinated diol and an ordered hard-segment extender. The chemical structure, thermal behavior, and mechanical properties were systematically characterized, while surface properties and biological performance were evaluated by water contact angle, protein adsorption, platelet adhesion, and cytotoxicity assays. The results demonstrated that fluorinated side chains preferentially enriched at the surface, forming a low-energy interface with significantly enhanced hydrophobicity. F-PCU exhibited excellent mechanical properties with a tensile strength of 49.5 MPa and an elongation at break of 965%. Notably, protein adsorption and platelet adhesion were substantially reduced, while good cytocompatibility was maintained, indicating improved surface hemocompatibility. These findings suggest that integrating ordered hard segments with fluorinated side chains is an effective strategy to optimize both bulk and surface properties, offering promising potential for long-term biomedical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.